Mankind Pharma shares slipped roughly 5% following a block trade in which 8.7% shares worth Rs 6,412 crore changed hands.
Following the transaction, the stock experienced significant selling pressure, with more than 2.15 crore shares trading on the NSE at 9:40 a.m. At around this time, the market value of the shares was Rs 3,964.18 crore.
With the block deals, the stock’s free float is likely to rise from about 10% to almost 20%. If the stock increases 18% over its present price by January 17, it may be included to the MSCI Index.
According to reports, a 7.9% equity block sale was proposed, with 6.9% as the base issue and 1% as the greenshoe option. The size of the issue is estimated to be between Rs 4,935 and Rs 5,649. The expected offer price per share was Rs 1,786 (a 7% decrease from the Monday closing price).
At around 11.45 AM, Mankind Pharma was trading 2.29% lower at Rs 1,876 per piece, against the previous close of Rs 1,920.04 on NSE.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.